Histogenics was incorporated in the state of Delaware in July 14, 2006.
When is Histogenics's fiscal year-end?
Who is Histogenics's independent registered public accounting firm?
Grant Thornton LLP
Who is Histogenics Corporate Counsel?
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP.
On which exchange is Histogenics listed and what is the ticker symbol?
Histogenics is traded on the NASDAQ stock exchange under the symbol “HSGX”.
When did Histogenics go public?
Histogenics went public on December 2, 2014.
How can I purchase shares?
Shares can be purchased through a stockbroker of your choice.
Does Histogenics have a direct stock purchase plan?
Histogenics does not offer a direct stock purchase plan.
Who is Histogenics's transfer agent and how do I contact them?
Histogenics's transfer agent is Broadridge Financial Solutions, Inc. (Broadridge). You can find more information about how to contact Broadridge at: http://www.broadridge.com/.
How can I replace my lost stock certificates?
Please contact our transfer agent, Broadridge Financial Solutions, Inc., at (877) 830-4936 or email@example.com. The company can look up your records and make any necessary adjustments. There is generally a fee involved for replacing lost certificates.
How do I report a change of mailing address?
You must send both your old and new addresses to our transfer agent, Broadridge Financial Solutions, Inc., by U.S. mail. Each stockholder in question must sign the request for an address change.
Where can I view documents that Histogenics has filed with the Securities & Exchange Commission (SEC)?
Histogenics' SEC filings can be accessed under "Financials & Filings" in the "Investors" section of our corporate website or www.sec.gov.
Where can I find recent Histogenics press releases?
You can view our recent press releases by visiting the News section of our website. If you would like to receive email alerts regarding our press releases, please visit the “Investors” section of our corporate website and choose the "Email Alerts" icon under “Shareholder Tools” to be added to the Histogenics distribution list.